Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 11, 2026
DataAggregated Company Financials
Companies7
- 7D-0.4%
- 3M7.0%
- 1Y-17.0%
- YTDn/a
Last week, the Clinical Research and Equipment industry hasn't moved much but IXICO is up 12% in that time. Unfortunately though, the industry is down 17% over the past 12 months. Earnings are forecast to grow by 56% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 12 Jul 2026 | UK£1.4b | UK£323.1m | -UK£164,731,254.00 | 1243.9x | -8.4x | 4.3x |
| Tue, 09 Jun 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1248.2x | -9x | 4.6x |
| Thu, 07 May 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -8x | 4.2x |
| Sat, 04 Apr 2026 | UK£1.4b | UK£323.0m | -UK£156,192,254.00 | 8.2x | -8.8x | 4.2x |
| Mon, 02 Mar 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 10.9x | -9.5x | 5x |
| Wed, 28 Jan 2026 | UK£1.9b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -11.8x | 6.2x |
| Fri, 26 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.8x | -9x | 4.7x |
| Sun, 23 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 7.5x | -9.2x | 4.9x |
| Tue, 21 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -9.7x | 5.2x |
| Thu, 18 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.2x | -11.4x | 5.7x |
| Sat, 16 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Mon, 14 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -10.1x | 5.6x |
| Wed, 11 Jun 2025 | UK£1.6b | UK£319.5m | -UK£190,894,115.50 | 7.6x | -8.4x | 5x |
| Fri, 09 May 2025 | UK£1.7b | UK£314.0m | -UK£192,537,929.75 | 11.2x | -9x | 5.5x |
| Sun, 06 Apr 2025 | UK£1.4b | UK£315.9m | -UK£186,638,286.55 | 5.7x | -7.7x | 4.5x |
| Tue, 04 Mar 2025 | UK£1.6b | UK£306.2m | -UK£195,420,794.16 | 6.4x | -8x | 5.1x |
| Thu, 30 Jan 2025 | UK£2.0b | UK£307.0m | -UK£195,589,675.68 | 7.4x | -10.4x | 6.6x |
| Sat, 28 Dec 2024 | UK£1.8b | UK£306.6m | -UK£195,272,697.36 | 7.6x | -9.4x | 6x |
| Mon, 25 Nov 2024 | UK£1.8b | UK£306.7m | -UK£193,151,466.80 | 8.6x | -9.3x | 5.9x |
| Wed, 23 Oct 2024 | UK£2.0b | UK£304.6m | -UK£192,519,892.30 | 11.2x | -10.6x | 6.7x |
| Fri, 20 Sep 2024 | UK£2.2b | UK£303.9m | -UK£191,748,504.00 | 11.4x | -11.6x | 7.3x |
| Sun, 18 Aug 2024 | UK£1.9b | UK£296.2m | -UK£188,767,577.70 | 12.3x | -9.9x | 6.3x |
| Tue, 16 Jul 2024 | UK£1.6b | UK£295.1m | -UK£189,594,705.03 | 11.5x | -8.6x | 5.5x |
| Thu, 13 Jun 2024 | UK£1.6b | UK£295.5m | -UK£189,690,076.47 | 11.7x | -8.5x | 5.5x |
| Sat, 11 May 2024 | UK£1.7b | UK£295.1m | -UK£187,865,864.75 | 6797.2x | -8.8x | 5.6x |
| Mon, 08 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,365,932.27 | 69.8x | -8.7x | 5.2x |
| Wed, 06 Mar 2024 | UK£1.8b | UK£285.7m | -UK£189,125,899.93 | 6787.3x | -9.6x | 6.4x |
| Fri, 02 Feb 2024 | UK£2.8b | UK£450.1m | -UK£176,485,267.00 | 69.5x | -16.1x | 6.3x |
| Sun, 31 Dec 2023 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
| Tue, 28 Nov 2023 | UK£3.0b | UK£455.4m | -UK£168,505,380.00 | 49.9x | -18.1x | 6.7x |
| Thu, 26 Oct 2023 | UK£2.9b | UK£458.8m | -UK£165,692,329.00 | 47.1x | -17.7x | 6.4x |
| Sat, 23 Sep 2023 | UK£3.1b | UK£441.0m | -UK£167,413,359.00 | 67.5x | -18.3x | 6.9x |
| Mon, 21 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,481,538.00 | 70.6x | -24.3x | 6.4x |
| Wed, 19 Jul 2023 | UK£3.3b | UK£475.7m | -UK£124,139,202.00 | 69.6x | -26.4x | 6.9x |
Price to Earnings Ratio
-26.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | -1.66% | |
| Healthcare | -7.62% | |
| Life Sciences | -0.40% | |
| Clinical Research and Equipment | -0.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IXI IXICO | UK£0.092 | 12.1% +UK£2.2m | -5.1% | PS2.8x | |
| PRM Proteome Sciences | UK£0.017 | 4.6% +UK£263.0k | -44.1% | PS1.6x |